Nutritional Knowledge and Characteristics of HYROX Athletes (NU-KCHA)

April 13, 2026 updated by: Jose Miguel Martinez Sanz, University of Alicante

Nutritional Knowledge and Characteristics of HYROX Athletes: A Cross-Sectional Study

This is an observational study aiming to assess the nutritional knowledge, dietary habits, supplement use, body composition, and physiological profiles of HYROX athletes. The main objective is to describe and evaluate the nutritional, anthropometric, and performance-related characteristics of these athletes to better understand factors influencing race performance. The main question it seeks to answer is: What are the nutritional, kinanthropometric, and physiological profiles of HYROX athletes, and how are dietary practices, supplement use, and body composition associated with their performance?

Study Overview

Detailed Description

HYROX athletes represent a unique cohort characterized by specific nutritional, physiological, and multi-modal performance demands, including body composition, strength, and endurance. Despite the global growth of hybrid fitness competitions, empirical evidence regarding the dietary practices, nutritional knowledge, and body composition of these athletes remains limited. This study addresses this gap through a comprehensive cross-sectional assessment of competitive HYROX athletes.

Data were collected using validated online questionnaires, including a Short Food Frequency Questionnaire (SFFFQ) to evaluate dietary intake, a 20-item supplement use questionnaire assessing consumption patterns, beliefs, and knowledge, and the Abbreviated Nutrition for Sport Knowledge Questionnaire (A-NSKQ) to measure nutritional knowledge. Eating behaviors and potential disordered eating were screened using the EAT-26 and the Figure Rating Scale (FRS). This structured protocol enables a detailed characterization of dietary habits, supplementation practices, nutritional knowledge, and body composition among HYROX athletes. By synthesizing these metrics, the study establishes a foundational characterization of the hybrid athlete, identifying physiological risks and providing the evidence-based framework necessary to optimize competitive performance

Study Type

Observational

Enrollment (Estimated)

122

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Alicante
      • Alicante, Alicante, Spain, 03690
        • Recruiting
        • Faculty of Health Sciences. University of Alicante
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

HYROX athletes

Description

Inclusion Criteria:

  • competitive HYROX athletes
  • age 18 or older
  • having participated in at least one official HYROX competition in the past 24 months

Exclusion Criteria:

- Participants not included in the Pro or Open categories were excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Male athletes
Competitive male athletes
Female athletes
Competitive female athletes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary intake
Time Frame: 5 years
A validated Short Food Frequency Questionnaire (SFFFQ) will be used to assess dietary quality. The questionnaire consists of 20 items covering key food groups, including fruits, vegetables, high-fiber foods, high-fat and sugary foods, meat and meat products, and fish. Participants are asked to report the frequency of foods and beverages consumed during a "typical week" over the past month. Response options range from "rarely or never" to "more than five times per day." The final score will be calculated based on the extent to which participants meet the UK dietary recommendations.
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition
Time Frame: 5 years
Assess body composition by anthropometry to estimate muscle mass and fat mass
5 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eating behaviours disorders
Time Frame: 5 years
Information on eating disorders will be collected using the EAT-26 test and the Figure Rating Scale (FRS). The EAT-26 comprises three subscales: Diet, Bulimia, and Oral Control, with responses on a 5-point Likert scale from 1 (Never) to 5 (Always). It also includes five questions related to disordered eating behaviors to identify athletes at risk, with a score of 20 or more suggesting possible eating disorders. The FRS is a visual tool assessing body image and perceived body size, with nine male and nine female figures ranging from very thin (1) to overweight (9).
5 years
Nutritional Knowledge
Time Frame: 5 years
Nutritional knowledge will be assessed with the Abbreviated Nutrition for Sport Knowledge Questionnaire (A-NSKQ), divided into two subsections: the first with 17 items on general nutrition knowledge, and the second with 20 items focused on athletes' knowledge about macronutrient and fluid requirements, weight loss and gain strategies, and dietary supplements. Each correct answer is awarded +1 point, while each incorrect answer is assigned -1 point. The maximum possible score is 59 points, and the minimum possible score (all answers incorrect) is -59 points. The questionnaire is divided into four sections: Macronutrients: 29 points (equivalent to 49.1 on a 0-100 scale), micronutrients: 19 points (32.2 on a 0-100 scale), hydration: 8 points (13.6 on a 0-100 scale) and periodization: 3 points (5.1 on a 0-100 scale).
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2025

Primary Completion (Estimated)

January 8, 2027

Study Completion (Estimated)

June 28, 2031

Study Registration Dates

First Submitted

March 23, 2026

First Submitted That Met QC Criteria

April 13, 2026

First Posted (Actual)

April 15, 2026

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • UA-2025-07-14

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data are available from the authors on request from the IP JMMS (josemiguel.ms@ua.es).

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe